SK¹ÙÀÌ¿À»çÀ̾ð½º, ±¹³» Äڷγª¹é½Å À¯Å롤°ü¸® ¸Ã´Â´Ù

ÃÖ¾Ö¸® ±âÀÚ | ±â»çÀÔ·Â 2021/01/22 [15:37]

¡ã °æºÏ ¾Èµ¿½Ã SK¹ÙÀÌ¿À»çÀ̾𽺠°øÀå¿¡¼­´Â ±¹¹ÎµéÀÇ Äڷγª19 ¿¹¹æ Á¢Á¾À» À§ÇØ °ø±ÞµÉ ¾Æ½ºÆ®¶óÁ¦³×Ä« ¹é½ÅÀ» À§Å¹»ý»êÇϰí ÀÖ´Ù. 2021.01.20.     © ´º½Ã½º


ºê·¹ÀÌÅ©´º½º ÃÖ¾Ö¸® ±âÀÚ= SK¹ÙÀÌ¿À»çÀ̾𽺰¡ ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(Äڷγª19) ¹é½ÅÀÇ ±¹³» À¯ÅëÀ» ¸ÃÀ» ¿¹Á¤ÀÌ´Ù.

 

Áúº´°ü¸®Ã»Àº 22ÀÏ ¿ÀÈÄ ¼³¸íÀڷḦ ÅëÇØ Äڷγª19 ¹é½Å º¸°ü ¹× À¯Åëü°è ±¸Ãà °ü·Ã ÁøÇà »óȲÀ» ÀüÇϸç À̰°ÀÌ ¹àÇû´Ù.

 

Áúº´Ã»Àº "21ÀÏ Äڷγª19 ¹é½Å À¯Åë°ü¸®Ã¼°è ±¸Ãࡤ¿î¿µ »ç¾÷ ¼öÇà±â°üÀ¸·Î SK¹ÙÀÌ¿À»çÀ̾𽺰¡ ¼±Á¤µÅ °è¾à ü°áÀÌ ¿Ï·áµÆ´Ù"¸ç "¾Æ½ºÆ®¶óÁ¦³×Ä«, ¾á¼¾, È­ÀÌÀÚ ¹é½Å ¹× Äڹ齺 ÆÛ½Ç¸®Æ¼(Covax Facility) ¹é½Å ¹°·®¿¡ ´ëÇÑ À¯Å롤º¸°üÀ» ´ã´çÇÏ°Ô µÈ´Ù"°í ¹àÇû´Ù.

 

Áúº´Ã»¿¡ µû¸£¸é SK¹ÙÀÌ¿À»çÀ̾𽺴 ¹é½Åº° ¸ÂÃãÇü °ü¸®Ã¼°è¸¦ ±¸ÃàÇϰí, ¹é½Å ¿î¼Û Áß ½Ç½Ã°£À¸·Î ¹é½Å ¿Âµµ À¯Áö ¿©ºÎ, ¹è¼Û °æ·Î µîÀ» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â »ç¹°ÀÎÅͳÝ(IoT) ±â¹ÝÀÇ ½Ã½ºÅÛÀ» ¿î¿µÇÒ °èȹÀÌ´Ù. ¶ÇÇÑ ±¹³» ¹°·ù¾÷ü µî°ú Çù·ÂÇØ ¹é½Å °ø±Þ À¯µ¿¼º¿¡ ´ëºñÇÑ ³Ãµ¿¡¤³ÃÀå ¹°·ù¼¾Å͸¦ ±¸ÃàÇØ ¿î¿µÇÑ´Ù.

 

¾Æ¿ï·¯ mRNA ±â¹ÝÀÇ È­ÀÌÀÚ ¹é½Å µîÀº -70µµ ÃÊÀú¿Â ³Ãµ¿ º¸°ü¹× À¯ÅëÀÌ ÇʼöÀûÀÌ´Ù. Á¤ºÎ´Â ÀÌ¿¡ µû¶ó ÃÊÀú¿Â ³Ãµ¿°í¸¦ È®º¸ÇØ mRNA ¹é½Å Á¢Á¾ÀÌ °¡´ÉÇϵµ·Ï ´ëÀÀÇÒ ¿¹Á¤ÀÌ´Ù.  

 

Áúº´Ã»Àº "È­ÀÌÀÚ ¹é½Å À¯ÁöÀÇ Çʼö ¹°Ç°ÀÎ ÃÊÀú¿Â ³Ãµ¿°í¸¦ °¢ Á¢Á¾¼¾ÅÍ¿¡ ¼³Ä¡ Áغñ Áß¿¡ ÀÖ´Ù"¸é¼­ "mRNA ¹é½Å Á¢Á¾±â°üÀÎ Á¢Á¾¼¾Åͺ°·Î ÃÊÀú¿Â ³Ãµ¿°í¸¦ ±¸ºñ¡¤¼³Ä¡ÇÏ°í ¹é½Å º¸°ü Á¶°ÇÀ» À¯Áö, ¹é½Å À¯È¿±â°£ ³» Â÷Áú ¾øÀÌ Á¢Á¾ÀÌ ½ÃÇàµÉ ¼ö ÀÖµµ·Ï ÇÒ °èȹ"À̶ó°í ¼³¸íÇß´Ù.

 

Á¤Àº°æ Áúº´°ü¸®Ã»ÀåÀº "¹é½ÅÀÇ Ã¶ÀúÇÑ À¯Åë°ü¸®Ã¼°è ±¸ÃàÀº ¾ÈÀüÇÑ Á¢Á¾À» À§ÇÑ °¡Àå Áß¿äÇÑ ÇÙ½É ¾÷¹«"¶ó¸ç "Á¢Á¾ ½ÃÇà Àü±îÁö ¼¼½ÉÇϰí Â÷Áú ¾øÀÌ ÁغñÇØ ³ª°¥ °Í"À̶ó°í ¸»Çß´Ù.

 

*¾Æ·¡´Â À§ ±â»ç¸¦ ±¸±Û ¹ø¿ª±â·Î ¹ø¿ªÇÑ ¿µ¹® ±â»çÀÇ [Àü¹®]ÀÌ´Ù. [Below is the [full text] of an English article translated from the above article with Google Translate.]

 

SK Bioscience, in charge of distribution and management of corona vaccine in Korea

 

SK Bioscience will be in charge of domestic distribution of a novel coronavirus infection (Corona 19) vaccine.

 

On the afternoon of the 22nd, the Korea Centers for Disease Control and Prevention (KCDC) announced the progress of the COVID-19 vaccine storage and distribution system through explanatory data.

 

The Agency for Disease Control and Prevention said, "On the 21st, SK Bioscience was selected as the agency for the establishment and operation of the COVID-19 vaccine distribution management system, and the contract was concluded." I will be in charge of distribution and storage of the product.¡±

 

According to the Korea Disease Administration, SK Bioscience plans to establish a customized management system for each vaccine and operate an Internet of Things (IoT)-based system that can monitor whether the vaccine temperature is maintained in real time and the delivery route during vaccine transportation. In addition, in cooperation with domestic logistics companies, it will establish and operate a frozen and refrigerated distribution center to prepare for the liquidity of vaccine supply.

 

In addition, it is essential to store and distribute mRNA-based Pfizer vaccines at -70 degrees Celsius frozen. Accordingly, the government plans to secure a cryogenic freezer to enable mRNA vaccination.

 

The Agency for Disease Control and Prevention said, "We are preparing to install a cryogenic freezer, which is an essential item for Pfizer vaccine maintenance, at each vaccination center." "We plan to allow vaccination to be performed without it."

 

"The establishment of a thorough distribution management system for vaccines is the most important task for safe vaccination," said Chung Eun-kyung, head of the Korea Centers for Disease Control and Prevention.

±â»çÁ¦º¸ ¹× º¸µµÀÚ·á 119@breaknews.com
¨Ï Çѱ¹¾ð·ÐÀÇ ¼¼´ë±³Ã¼ ºê·¹ÀÌÅ©´º½º / ¹«´ÜÀüÀç ¹× Àç¹èÆ÷±ÝÁö
 

ÀÌ ±â»ç¸¦ ÈÄ¿øÇÏ°í ½Í½À´Ï´Ù.

µ¶ÀÚ´ÔÀÇ ÀÛÀº ÀÀ¿øÀÌ Å« ÈûÀÌ µË´Ï´Ù.
ÈÄ¿ø±ÝÀº ÀÎÅÍ³Ý ½Å¹®»ç 'ºê·¹ÀÌÅ©´º½º' ¹ßÀü¿¡ ¾²¿©Áý´Ï´Ù.
´Ð³×ÀÓ ÆÐ½º¿öµå µµ¹è¹æÁö ¼ýÀÚ ÀÔ·Â
³»¿ë
±â»ç ³»¿ë°ú °ü·ÃÀÌ ¾ø´Â ±Û, ¿å¼³À» »ç¿ëÇÏ´Â µî ŸÀÎÀÇ ¸í¿¹¸¦ ÈѼÕÇÏ´Â ±ÛÀº °ü¸®ÀÚ¿¡ ÀÇÇØ ¿¹°í ¾øÀÌ ÀÓÀÇ »èÁ¦µÉ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇϽñ⠹ٶø´Ï´Ù.
 
±¤°í


±¤°í